secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0000950170-23-000462
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical reports Q4 2022 expected revenue ~$31.5M; guides FY2023 revenue $140-150M
--------------------------------------------------------------------------------

- Q4 2022 expected revenue ~$31.5M (+13% QoQ); FY2022 expected revenue ~$115M (+12% YoY).
- Installed base of Tablo systems grew 54% YoY to ~4,000; home provider units doubled to ~800.
- FY2022 non-GAAP gross margin expected in mid-teens; FY2023 guidance: ~20% full year, mid-20% exit Q4.
- 2023 revenue guidance $140M-$150M (22-30% growth over 2022 expected revenue).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017023000462/0000950170-23-000462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017023000462/om-20230109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer